Skip to content

Training Induced Muscle Exosome Release

Muscle-derived Extracellular Vesicles and Their Interactions With Adipocytes in Human Metabolic Dysfunction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04500769
Acronym
TIMER
Enrollment
38
Registered
2020-08-05
Start date
2019-03-14
Completion date
2022-11-30
Last updated
2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolism

Keywords

Metabolism, Muscle, Extracellular Vesicles, Exosomes, Resistance Exercise

Brief summary

The primary objective of this study is to quantify miR-1 release from muscle in extra-cellular vesicles following an acute resistance exercise bout and potential delivery to subcutaneous adipose tissue in young healthy and obese adults.

Detailed description

Numerous studies in humans and animals have shown that aerobic exercise is beneficial to adipose tissue function and whole-body metabolism. Both acute and chronic aerobic exercise enhance adipocyte catecholamine sensitivity in humans and animals. Although relatively few studies have investigated whether adipose adrenergic signaling is affected by resistance exercise (RE), it is known that a single bout of RE can increase circulating NEFA and resting energy expenditure and decrease respiratory quotient for up to 24 hours, indicative of increased adipocyte lipolysis and muscle fatty acid oxidation. Furthermore, the lipolytic response to RE is impaired in obese men. Using synergist ablation, a model of RE in mice, the investigators show that adipose transcriptional responses are exosome-dependent, and that serum exosomes enhance adipocyte catecholamine sensitivity and lipolysis for at least 24 hours. To the investigator's knowledge, this is the first demonstration of a potential mechanism whereby RE imparts metabolic adaptations in adipose. Since adipose metabolic function is crucial for determining whole-body metabolic outcomes, the ability of RE-induced exosomes to improve adipose metabolism has significant clinical implications.

Interventions

Participants will perform three sets of eight repetitions, with a 90-120 second rest between sets, with a fourth set performed to failure. All resistance exercise will be performed on pneumatic resistance devices (Keiser Sports Health Equipment, Fresno, CA).

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Yuan Wen
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-30 years of age. * Either BMI \<25 or \>30. * Relatively sedentary, reporting no participation in regular (\>1 day per week) exercise for at least the past 3 months. * Non-smoker.

Exclusion criteria

* BMI between 25 and 30. * Evidence or signs and symptoms for cardiovascular disease (previous heart attack, arrhythmias, angina, shortness of breath, extreme fatigue, unusual pain in neck, jaw, throat, upper abdomen, or back, swelling in feet, legs, or ankles). * Evidence or signs and symptoms of metabolic syndrome or disorder (diagnosis of diabetes or insulin resistance, elevated BP, high fasting blood sugar, abnormal cholesterol or triglyceride levels). * Chronic aspirin or NSAID use (unless it can be safely stopped prior to the biopsies), and any other use of an anticoagulant (e.g., Coumadin) or history of bleeding including history of hypo- or hyper-coagulation disorders. * Neurological, musculoskeletal, or other disorder that would preclude safe participation in the weight lifting tasks and all performance tests. * Any other medical condition that would interfere with testing or increase one's risk of complications during exercise, as judged by the study physician. * Any other condition or events considered exclusionary by the PI and/or physician, such as non-compliance. * Lidocaine allergy (1% lidocaine is the local anesthetic used during the muscle biopsy procedure). * Pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
miR-1 Abundance90 minutesExosomal, muscle, and adipose miR-1 abundance will be quantified at baseline and following an acute bout of resistance exercise by qPCR.

Countries

United States

Participant flow

Recruitment details

Subjects were actively recruited from the University of Kentucky campus as well as from the surrounding Lexington community through local advertisement using IRB approved recruitment flyers or newspaper advertisement. Recruitment occurred between March of 2019 and November 2022.

Pre-assignment details

Consent and baseline assessments were conducted prior to the resistance exercise intervention. Baseline assessments included demographics, medications, personal health and medical history, vitals, and physical activity readiness. Baseline assessment of strength was also conducted for each resistance exercise so that relative intensity could be standardized for each participant. All participants completed the same resistance exercise bout.

Participants by arm

ArmCount
Acute Resistance Exercise
Participants will perform four exercises: squat, knee extension, leg press, and lat pulldown at 80% of 1-RM determined during a previous visit. Acute Resistance Exercise: Participants will perform three sets of eight repetitions, with a 90-120 second rest between sets, with a fourth set performed to failure. All resistance exercise will be performed on pneumatic resistance devices (Keiser Sports Health Equipment, Fresno, CA).
38
Total38

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject5

Baseline characteristics

CharacteristicAcute Resistance Exercise
Age, Continuous28.71 years
STANDARD_DEVIATION 5.99
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
37 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
4 Participants
Race (NIH/OMB)
Black or African American
2 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
31 Participants
Region of Enrollment
United States
38 participants
Sex: Female, Male
Female
18 Participants
Sex: Female, Male
Male
20 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 38
other
Total, other adverse events
12 / 38
serious
Total, serious adverse events
0 / 38

Outcome results

Primary

miR-1 Abundance

Exosomal, muscle, and adipose miR-1 abundance will be quantified at baseline and following an acute bout of resistance exercise by qPCR.

Time frame: 90 minutes

ArmMeasureGroupValue (MEAN)Dispersion
Acute Resistance ExercisemiR-1 AbundancePercent change in serum EV miR-1 with exercise226 percent changeStandard Deviation 313
Acute Resistance ExercisemiR-1 AbundancePercent change in muscle miR-1 with exercise110 percent changeStandard Deviation 82
Acute Resistance ExercisemiR-1 AbundancePercent change in adipose miR-1 with exercise286 percent changeStandard Deviation 464

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026